PlainRecalls
FDA Drug Low Class III Terminated

Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12

Reported: July 29, 2020 Initiated: June 17, 2020 #D-1392-2020

Product Description

Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12

Reason for Recall

TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.

Details

Recalling Firm
HF Acquisition Co. LLC
Units Affected
N/A
Distribution
The vials were distributed to one consignee located in CT.
Location
Mukilteo, WA

Frequently Asked Questions

What product was recalled?
Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12. Recalled by HF Acquisition Co. LLC. Units affected: N/A.
Why was this product recalled?
TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 29, 2020. Severity: Low. Recall number: D-1392-2020.